RxSight, Inc. (RXST) stock
RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3076% below fair value
$5.01+0.18 (+3.73%)
Close on Nov 18, 2026Market cap $208.38MP/E –Yield –
RxSight revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
RxSight's revenue for the twelve months ending Jun 30, 2026 was $127.58M, down 13.2% year over year. For fiscal 2025 it was $134.48M, down 3.9% from the year before. The highest annual figure on record is $139.93M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $134.48M | -3.9% |
| FY2024 | Dec 31, 2024 | $139.93M | +57.1% |
| FY2023 | Dec 31, 2023 | $89.08M | +81.8% |
| FY2022 | Dec 31, 2022 | $49.01M | +116.9% |
| FY2021 | Dec 31, 2021 | $22.59M | +53.9% |
| FY2020 | Dec 31, 2020 | $14.68M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $33.74M | +0.3% |
| Q1 FY2026 | Mar 31, 2026 | $30.89M | -18.5% |
| Q4 FY2025 | Dec 31, 2025 | $32.61M | -18.9% |
| Q3 FY2025 | Sep 30, 2025 | $30.34M | -14.1% |
| Q2 FY2025 | Jun 30, 2025 | $33.64M | -3.6% |
| Q1 FY2025 | Mar 31, 2025 | $37.90M | +28.4% |
| Q4 FY2024 | Dec 31, 2024 | $40.21M | +40.7% |
| Q3 FY2024 | Sep 30, 2024 | $35.31M | +59.1% |
| Q2 FY2024 | Jun 30, 2024 | $34.89M | +67.6% |
| Q1 FY2024 | Mar 31, 2024 | $29.51M | +68.7% |
| Q4 FY2023 | Dec 31, 2023 | $28.58M | +77.6% |
| Q3 FY2023 | Sep 30, 2023 | $22.20M | +76.0% |
| Q2 FY2023 | Jun 30, 2023 | $20.81M | +83.2% |
| Q1 FY2023 | Mar 31, 2023 | $17.49M | +95.6% |
| Q4 FY2022 | Dec 31, 2022 | $16.09M | +90.9% |
| Q3 FY2022 | Sep 30, 2022 | $12.62M | +118.0% |
| Q2 FY2022 | Jun 30, 2022 | $11.36M | +132.0% |
| Q1 FY2022 | Mar 31, 2022 | $8.94M | +156.7% |
| Q4 FY2021 | Dec 31, 2021 | $8.43M | +71.5% |
| Q3 FY2021 | Sep 30, 2021 | $5.79M | +38.8% |
| Q2 FY2021 | Jun 30, 2021 | $4.90M | +81.0% |
| Q1 FY2021 | Mar 31, 2021 | $3.48M | – |
| Q4 FY2020 | Dec 31, 2020 | $4.91M | – |
| Q3 FY2020 | Sep 30, 2020 | $4.17M | – |
| Q2 FY2020 | Jun 30, 2020 | $2.71M | – |
See a number that looks wrong?